GlassScriptPhysician profile
Maximiliano Arroyo
NPI 1437376548
$46,462.01
in general payments reported to CMS, 2019-2025
29 companies · $2,368 in 2025
The $2,368 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,858 · 2021: $2,513 · 2022: $1,519 · 2023: $3,138 · 2024: $18K · 2025: $2,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,800 · Food and Beverage: $7,104 · Consulting Fee: $4,938 · Travel and Lodging: $3,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,800.00 |
| Food and Beverage | $7,103.59 |
| Consulting Fee | $4,937.50 |
| Travel and Lodging | $3,551.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,823.18 | 2019-2025 | Ekosonic, Avvigo Guidance System, General - Therapies |
| Abiomed | $10,768.93 | 2019-2025 | Impella |
| Abbott Laboratories | $1,330.99 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jeti Peripheral Catheter, Aveir |
| Avinger INC. | $697.07 | 2021-2023 | Pantheris |
| Janssen Pharmaceuticals, INC | $461.49 | 2019-2022 | |
| Shockwave Medical, INC | $448.36 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $354.13 | 2023-2024 | Indigo System, Penumbra System, Smart Coil |
| Edwards Lifesciences Corporation | $270.24 | 2020-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $152.73 | 2022-2025 | Pulseselect, Affera Mapping System |
| Amgen INC. | $133.91 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $116.07 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $113.61 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Angiodynamics, INC. | $106.29 | 2025 | Alphavac |
| Astrazeneca Pharmaceuticals LP | $100.79 | 2019-2024 | Farxiga |
| Asahi Intecc USA, INC. | $96.10 | 2021-2023 | Asahi Ptca Guide Wire |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $95.98 | 2019-2023 | Carto 3 |
| Pfizer INC. | $79.42 | 2019-2021 | |
| Terumo Medical Corporation | $75.28 | 2019-2025 | Metacross Otw, Glidesheath Slender, Glidewire |
| Livanova USA, INC. | $53.34 | 2023 | Lifesparc |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.08 | 2019-2023 | Lifevest |
| Biotronik INC. | $42.56 | 2020-2022 | |
| Lantheus Medical Imaging, INC. | $15.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.20 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $13.77 | 2023 | |
| Cordis US Corp. | $13.29 | 2023 | Selution Slrpta |
| Cvrx, INC. | $11.37 | 2024 | Barostim Neo System |
| Elutia, INC. | $11.18 | 2019 | |
| Cardinal Health 200 LLC | $11.07 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maximiliano Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.